Moving Regenerative Medicine from the Lab to the Patient

Pharmaceutical, Biotechnology and Medical Device Industries Partner Michael Werner will speak at the Reimbursement Strategies Webinar on "Moving Regenerative Medicine from the Lab to the Patient."

Topics

• primer on coding, coverage and payment rules and processes that determine whether a regenerative medicine product will be reimbursed
• understanding why you should develop and adopt a reimbursement strategy early in product development
• understanding how your reimbursement strategy and regulatory strategy coincide
• understanding how new reimbursement rules and payment models such as ACOs, payment bundling and comparative effectiveness analysis will affect regenerative medicine technologies and develop strategies to succeed
• questions and answers